MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
47.52
+0.23 (0.49%)
At close: Jun 27, 2025, 4:00 PM
46.60
-0.92 (-1.94%)
After-hours: Jun 27, 2025, 4:39 PM EDT

MLTX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
3,0163,4153,620409-
Market Cap Growth
-21.71%-5.66%784.47%--
Enterprise Value
2,6122,9323,189353-
Last Close Price
43.5054.1560.3910.509.89
PB Ratio
6.787.537.055.95-
P/TBV Ratio
7.407.647.308.37-
Debt / Equity Ratio
0.180.010.010.00-1.29
Quick Ratio
20.1520.0751.389.440.39
Current Ratio
21.1121.1151.599.980.46
Return on Equity (ROE)
-30.64%-25.08%-15.14%-225.86%-
Return on Assets (ROA)
-19.85%-17.81%-11.21%-93.99%-
Return on Capital (ROIC)
-20.44%-18.38%-11.54%-112.32%-
Earnings Yield
-4.81%-3.48%-1.00%-12.21%-
FCF Yield
-4.65%-3.43%-1.19%-13.66%-
Buyback Yield / Dilution
-14.55%-27.99%-67.30%-274.47%-
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q